EH4 Healthcare Limited SC455606 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is dentistry Digita Accounts Production Advanced 6.30.9574.0 true SC455606 2024-09-01 2025-08-31 SC455606 2025-08-31 SC455606 bus:Director2 1 2025-08-31 SC455606 core:CapitalRedemptionReserve 2025-08-31 SC455606 core:RetainedEarningsAccumulatedLosses 2025-08-31 SC455606 core:ShareCapital 2025-08-31 SC455606 core:CurrentFinancialInstruments 2025-08-31 SC455606 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 SC455606 core:Non-currentFinancialInstruments 2025-08-31 SC455606 core:Non-currentFinancialInstruments core:AfterOneYear 2025-08-31 SC455606 core:Goodwill 2025-08-31 SC455606 core:ConstructionInProgressAssetsUnderConstruction 2025-08-31 SC455606 core:FurnitureFittingsToolsEquipment 2025-08-31 SC455606 core:OtherPropertyPlantEquipment 2025-08-31 SC455606 bus:SmallEntities 2024-09-01 2025-08-31 SC455606 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 SC455606 bus:FilletedAccounts 2024-09-01 2025-08-31 SC455606 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 SC455606 bus:RegisteredOffice 2024-09-01 2025-08-31 SC455606 bus:Director1 2024-09-01 2025-08-31 SC455606 bus:Director2 2024-09-01 2025-08-31 SC455606 bus:Director2 1 2024-09-01 2025-08-31 SC455606 bus:Director3 2024-09-01 2025-08-31 SC455606 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 SC455606 bus:Agent1 2024-09-01 2025-08-31 SC455606 core:Goodwill 2024-09-01 2025-08-31 SC455606 core:Buildings 2024-09-01 2025-08-31 SC455606 core:ConstructionInProgressAssetsUnderConstruction 2024-09-01 2025-08-31 SC455606 core:FurnitureFittingsToolsEquipment 2024-09-01 2025-08-31 SC455606 core:Land 2024-09-01 2025-08-31 SC455606 core:OtherPropertyPlantEquipment 2024-09-01 2025-08-31 SC455606 core:PlantMachinery 2024-09-01 2025-08-31 SC455606 countries:Scotland 2024-09-01 2025-08-31 SC455606 2024-08-31 SC455606 bus:Director2 1 2024-08-31 SC455606 core:Goodwill 2024-08-31 SC455606 core:ConstructionInProgressAssetsUnderConstruction 2024-08-31 SC455606 core:FurnitureFittingsToolsEquipment 2024-08-31 SC455606 core:OtherPropertyPlantEquipment 2024-08-31 SC455606 2023-09-01 2024-08-31 SC455606 2024-08-31 SC455606 bus:Director2 1 2024-08-31 SC455606 bus:Director3 1 2024-08-31 SC455606 core:CapitalRedemptionReserve 2024-08-31 SC455606 core:RetainedEarningsAccumulatedLosses 2024-08-31 SC455606 core:ShareCapital 2024-08-31 SC455606 core:CurrentFinancialInstruments 2024-08-31 SC455606 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 SC455606 core:Non-currentFinancialInstruments 2024-08-31 SC455606 core:Non-currentFinancialInstruments core:AfterOneYear 2024-08-31 SC455606 core:Goodwill 2024-08-31 SC455606 core:ConstructionInProgressAssetsUnderConstruction 2024-08-31 SC455606 core:FurnitureFittingsToolsEquipment 2024-08-31 SC455606 core:OtherPropertyPlantEquipment 2024-08-31 SC455606 bus:Director2 1 2023-09-01 2024-08-31 SC455606 bus:Director3 1 2023-09-01 2024-08-31 SC455606 bus:Director2 1 2023-08-31 SC455606 bus:Director3 1 2023-08-31 iso4217:GBP xbrli:pure

REGISTRAR OF COMPANIES

Registration number: SC455606

EH4 Healthcare Limited

Unaudited Financial Statements

31 August 2025

image-name

 

EH4 Healthcare Limited

Contents

Accountants' Report

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

4

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
EH4 Healthcare Limited
for the Year Ended 31 August 2025

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of EH4 Healthcare Limited for the year ended 31 August 2025 as set out on pages 2 to 11 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of EH4 Healthcare Limited, as a body, in accordance with the terms of our engagement letter dated 23 February 2024. Our work has been undertaken solely to prepare for your approval the accounts of EH4 Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of EH4 Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than EH4 Healthcare Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that EH4 Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of EH4 Healthcare Limited. You consider that EH4 Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of EH4 Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.



Dodd & Co Limited
Chartered Accountants
Clint Mill
Cornmarket
PENRITH
CA11 7HW

21 November 2025

 

EH4 Healthcare Limited

(Registration number: SC455606)
Balance Sheet as at 31 August 2025

Note

2025
£

2024
£

Fixed assets

 

Intangible assets

4

197,212

242,438

Tangible assets

5

173,303

149,291

 

370,515

391,729

Current assets

 

Stocks

3,333

3,333

Debtors

6

61,508

10,956

Cash at bank and in hand

 

434,672

395,662

 

499,513

409,951

Creditors: Amounts falling due within one year

7

(184,371)

(268,356)

Net current assets

 

315,142

141,595

Total assets less current liabilities

 

685,657

533,324

Creditors: Amounts falling due after more than one year

7

(247,610)

(250,414)

Provisions for liabilities

(38,342)

(29,743)

Net assets

 

399,705

253,167

Capital and reserves

 

Allotted, called up and fully paid share capital

2

2

Capital redemption reserve

1

1

Profit and loss account

399,702

253,164

Total equity

 

399,705

253,167

 

EH4 Healthcare Limited

(Registration number: SC455606)
Balance Sheet as at 31 August 2025 (continued)

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 21 November 2025 and signed on its behalf by:
 

.........................................

K Ollerhead

Director

.........................................

I S Ollerhead

Director

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
461 Queensferry Road
EDINBURGH
EH4 7ND

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when the amount of revenue can be reliably measured; it is probable that future economic benefits will flow to the entity; and specific criteria have been met for each of the company's activities.


Government grants
Grants relating to revenue are recognised in the profit and loss account on a systematic basis over the periods in which the related costs are recognised for which the grant is intended to compensate.

Grants for the purpose of giving immediate financial support with no future related costs to be incurred are recognised in the profit and loss account when the grant proceeds become receivable.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Land and buildings

20 years straight line basis

Improvements to property

20 years straight line basis

Plant and equipment

25% reducing balance basis

Furniture, fittings and office equipment

15% reducing balance and 3 years straight line bases

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

10 year straight line basis

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for the sale of goods or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method where due after more than one year.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 17 (2024 - 16).

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

4

Intangible assets

Goodwill
 £

Total
£

Cost or valuation

At 1 September 2024

800,140

800,140

At 31 August 2025

800,140

800,140

Amortisation

At 1 September 2024

557,702

557,702

Amortisation charge

45,226

45,226

At 31 August 2025

602,928

602,928

Carrying amount

At 31 August 2025

197,212

197,212

At 31 August 2024

242,438

242,438

5

Tangible assets

Improvements to property
 £

Plant and equipment
 £

Furniture, fittings and office equipment
 £

Total
£

Cost or valuation

At 1 September 2024

59,357

317,601

41,577

418,535

Additions

1,590

51,962

3,291

56,843

At 31 August 2025

60,947

369,563

44,868

475,378

Depreciation

At 1 September 2024

28,034

206,198

35,008

269,240

Charge for the year

2,974

28,480

1,381

32,835

At 31 August 2025

31,008

234,678

36,389

302,075

Carrying amount

At 31 August 2025

29,939

134,885

8,479

173,303

At 31 August 2024

31,323

111,401

6,567

149,291

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

6

Debtors

2025
£

2024
£

Trade debtors

8,182

10,097

Other debtors

53,326

859

61,508

10,956

7

Creditors

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

8

29,055

15,873

Trade creditors

 

45,699

68,390

Taxation and social security

 

14,698

20,199

Corporation tax liability

 

86,336

156,305

Other creditors

 

8,583

7,589

 

184,371

268,356

Due after one year

 

Loans and borrowings

8

247,610

250,414

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

8

Loans and borrowings

2025
£

2024
£

Current loans and borrowings

Bank borrowings

21,777

15,873

Finance lease liabilities

7,278

-

29,055

15,873

Current loans and borrowings includes the following liabilities, on which security has been given by the company:

2025
£

2024
£

Finance lease liabilities

7,278

-

Bank borrowings

21,777

15,873

29,055

15,873

Current finance lease liabilities are secured against the assets to which they relate. Current bank borrowings are secured by fixed and floating charges over the company's assets.

2025
£

2024
£

Non-current loans and borrowings

Bank borrowings

233,053

250,414

Finance lease liabilities

14,557

-

247,610

250,414

Non-current loans and borrowings includes the following liabilities, on which security has been given by the company:

2025
£

2024
£

Finance lease liabilities

14,557

-

Bank borrowings

233,053

250,414

247,610

250,414

Non-current finance lease liabilities are secured against the assets to which they relate. Non-current bank borrowings are secured by fixed and floating charges over the company's assets.

 

EH4 Healthcare Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 August 2025 (continued)

9

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £3,907 (2024 - £6,039). The company has an outstanding equipment lease with 22 months remaining.

10

Related party transactions

Transactions with directors

2025

At 1 September 2024
£

Advances
£

Repayments
£

Other payments
£

Dividends credited
£

Interest
£

At 31 August 2025
£

I S Ollerhead

Directors loan

702

50,098

-

-

(710)

1,262

51,352

               
         

 

2024

At 1 September 2023
£

Advances
£

Repayments
£

Other payments
£

Dividends credited
£

Interest
£

At 31 August 2024
£

I S Ollerhead

Directors loan

495

782

(75)

-

(500)

-

702

               
         

J M Gall

Directors loan

781

113

(94)

-

(800)

-

-

               
         

 

Directors' advances are repayable on demand.

Interest has been charged at a rate of 2.25% to March 2025 and 3.75% from April 2025 on advances to directors.